东宝生物：“东宝转债”预计触发转股价格向下修正条件

Core Points - The company Baotou Dongbao Biotechnology Co., Ltd. announced that from September 17 to September 30, 2025, its stock closing price has been below 90% of the current conversion price of 6.63 CNY per share for ten trading days, which is expected to trigger the downward adjustment condition for the "Dongbao Convertible Bonds" [1] - The total issuance amount of "Dongbao Convertible Bonds" is 455 million CNY, which was listed on August 18, 2023, with a conversion period from February 5, 2024, to July 30, 2029 [1] - If the adjustment condition is triggered, the company's board of directors has the authority to decide whether to propose an adjustment plan and submit it for shareholder meeting review, while fulfilling the necessary review procedures and information disclosure obligations [1]